Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

UTHR holding history

United Therapeutics Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of UTHR by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−99,106−100.0%Sold outHolders
Q1 202699,106$58.8M<0.1%−207,865−67.7%ReducedHolders
Q4 2025306,971$149.6M0.1%+242,260+374.4%AddedHolders
Q3 202564,711$27.1M<0.1%+43,103+199.5%AddedHolders
Q2 202521,608$6.21M<0.1%−8,658−28.6%ReducedHolders
Q1 202530,266$9.33M<0.1%−13,022−30.1%ReducedHolders
Q4 202443,288$15.3M<0.1%−8,262−16.0%ReducedHolders
Q3 202451,550$18.5M<0.1%+9,529+22.7%AddedHolders
Q2 202442,021$13.4M<0.1%−211−0.5%ReducedHolders
Q1 202442,232$9.70M<0.1%−47,467−52.9%ReducedHolders
Q4 202389,699$19.7M<0.1%+4,613+5.4%AddedHolders
Q3 202385,086$19.2M<0.1%−3,736−4.2%ReducedHolders
Q2 202388,822$19.6M<0.1%−78,905−47.0%ReducedHolders
Q1 2023167,727$37.6M0.1%+4,415+2.7%AddedHolders
Q4 2022163,312$45.4M0.1%+126,512+343.8%AddedHolders
Q3 202236,800$7.71M<0.1%−50,832−58.0%ReducedHolders
Q2 202287,632$20.6M<0.1%−11,684−11.8%ReducedHolders
Q1 202299,316$17.8M<0.1%−80,391−44.7%ReducedHolders
Q4 2021179,707$38.8M<0.1%−107,720−37.5%ReducedHolders
Q3 2021287,427$53.1M0.1%−102,121−26.2%ReducedHolders
Q2 2021389,548$69.9M0.1%+16,086+4.3%AddedHolders
Q1 2021373,462$62.5M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.